WT1 as a substrate of HtrA2: A potential pathway for therapeutic targeting by HtrA proteases

Future Oncology

Volumn 6, Issue 8, 2010, Pages 1233-1235

  Chien, Jeremy ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE OMI; WT1 PROTEIN;

CANCER GROWTH; CANCER INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEPHROBLASTOMA; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION;

EID: 77956317350     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.10.84     Document Type: Note

References (11)

1. Hartkamp J, Carpenter B, Roberts SG: The Wilms tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol. Cell 37(2), 159-171 (2010).
2. Klupsch K, Downward J: The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. Cell Death Differ. 13(12), 2157-2159 (2006).
3. Danial NN, Korsmeyer SJ: Cell death: critical control points. Cell 116(2), 205-219 (2004).
4. Igney FH, Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2(4), 277-288 (2002).
5. Leist M, Jaattela M: Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol. 2(8), 589-598 (2001).
6. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R: A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8(3), 613-621 (2001).
7. Clausen T, Southan C, Ehrmann M: The HtrA family of proteases: implications for protein composition and cell fate. Mol. Cell 10(3), 443-455 (2002).
8. Martins LM, Turk BE, Cowling V et al.: Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J. Chem. 278(49), 49417-49427 (2003).
9. Chien J, He X, Shridhar V: Identification of tubulins as substrates of serine protease HtrA1 by mixture-based oriented peptide library screening. J. Cell. Biochem. 107(2), 253-263 (2009).
10. Chien J, Aletti G, Baldi A et al.: Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J. Clin. Invest. 116(7), 1994-2004 (2006).
11. Beleford D, Rattan R, Chien J, Shridhar V: High temperature requirement A3 (HtrA3) promotes etoposide- and cisplatin-induced cytotoxicity in lung cancer cell lines. J. Biol Chem. 285(16), 12011-12027 (2010)